Abstract:Circulation Research, Ahead of Print. BACKGROUND:Cardiac hypertrophy is an adaptive response to pressure overload aimed at maintaining cardiac function. However, prolonged hypertrophy significantly increases the risk of maladaptive cardiac remodeling and heart failure. Recent studies have implicated long noncoding RNAs in cardiac hypertrophy and cardiomyopathy, but their significance and mechanism(s) of action are not well understood.METHODS:We measuredlincRNA-p21RNA and H3K27ac levels in the hearts of dilated cardiomyopathy patients. We assessed the functional role oflincRNA-p21in basal and surgical pressure-overload conditions using loss-of-function mice. Genome-wide transcriptome analysis revealed dysregulated genes and pathways. We labeled proteins in proximity to full-lengthlincRNA-p21using a novel BioID2-based system. We immunoprecipitatedlincRNA-p21-interacting proteins and performed cell fractionation, ChIP-seq (chromatin immunoprecipitation followed by sequencing), and co-immunoprecipitation to investigate molecular interactions and underlying mechanisms. We used GapmeR antisense oligonucleotides to evaluate the therapeutic potential oflincRNA-p21inhibition in cardiac hypertrophy and associated heart failure.RESULTS:lincRNA-p21was induced in mice and humans with cardiomyopathy. Global and cardiac-specificlincRNA-p21knockout significantly suppressed pressure overload-induced ventricular wall thickening, stress marker elevation, and deterioration of cardiac function. Genome-wide transcriptome analysis and transcriptional network analysis revealed thatlincRNA-p21actsin transto stimulate the NFAT/MEF2 pathway. Mechanistically,lincRNA-p21is bound to the scaffold protein KAP1.lincRNA-p21cardiac-specific knockout suppressed stress-induced nuclear accumulation of KAP1, and KAP1 knockdown attenuated cardiac hypertrophy and NFAT activation. KAP1 positively regulates pathological hypertrophy by physically interacting with NFATC4 to promote the overactive status of NFAT/MEF2 signaling. GapmeR antisense oligonucleotide depletion oflincRNA-p21similarly inhibited cardiac hypertrophy and adverse remodeling, highlighting the therapeutic potential of inhibitinglincRNA-p21.CONCLUSIONS:These findings advance our understanding of the functional significance of stress-induced long noncoding RNA in cardiac hypertrophy and demonstrate the potential oflincRNA-p21as a novel therapeutic target for cardiac hypertrophy and subsequent heart failure.

LincRNA‐p21 exon 1 expression correlates with Cdkn1a expression in vivo

LINP1 facilitates DNA damage repair through non-homologous end joining (NHEJ) pathway and subsequently decreases the sensitivity of cervical cancer cells to ionizing radiation.

Linc00901 Regulates Glucose Metabolism In Pancreatic Cancer.

LINC00346 Promotes Pancreatic Cancer Progression Through the CTCF-mediated Myc Transcription

Identification and characterization of an enhancer element regulating expression of Cdkn1c (p57 gene)

LncRNA LINC00525 suppresses p21 expression via mRNA decay and triplex‐mediated changes in chromatin structure in lung adenocarcinoma

Lincrna‑p21 Inhibits the Progression of Non‑small Cell Lung Cancer Via Targeting Mir‑17‑5p

Long intragenic non-coding RNA lincRNA-p21 suppresses development of human prostate cancer.

LncRNA KCNK15-AS1 inhibits pancreatic cancer progression by promoting the expression of its binding protein ACTR3B

p53-targeted lincRNA-p21 acts as a tumor suppressor by inhibiting JAK2/STAT3 signaling pathways in head and neck squamous cell carcinoma

LINC01857 promotes the development of gastric cancer by regulating microRNA-200b.

Lincrna-P21 Regulates Neointima Formation, Vascular Smooth Muscle Cell Proliferation, Apoptosis, and Atherosclerosis by Enhancing P53 Activity

Linc-Aam Facilitates Gene Expression Contributing to Macrophage Activation and Adaptive Immune Responses.

LincRNA-p21 Inhibits the Growth and Invasion of Pancreatic Cancer by Promoting Β-Catenin Ubiquitylation and Degradation

LincIN, a Novel NF90-binding Long Non-Coding RNA, is Overexpressed in Advanced Breast Tumors and Involved in Metastasis

The P53-Induced Lincrna-P21 Derails Somatic Cell Reprogramming by Sustaining H3K9me3 and CpG Methylation at Pluripotency Gene Promoters

LINC01021 Attenuates Expression and Affects Alternative Splicing of a Subset of p53-Regulated Genes

Linc00958 Promotes Lung Cancer Proliferation and Migration Through Regulating microRNA-490-3p

Therapeutic Inhibition of LincRNA-p21 Protects Against Cardiac Hypertrophy

Linc00152 Promotes Cancer Cell Proliferation and Invasion and Predicts Poor Prognosis in Lung Adenocarcinoma

Long Noncoding RNA LINC01296 Plays an Oncogenic Role in Colorectal Cancer by Suppressing P15 Expression